Standard Biotools | FLDM - Current Liabilities


Standard Biotools reported $42.2M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Agilent USD 2.27B 35M Mar/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Bio-Rad Laboratories USD 961.3M 44.3M Jun/2026
Bruker USD 1.2B 150.4M Jun/2026
Danaher USD 8.1B 645M Jun/2026
Illumina USD 1.58B 12M Jun/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Nikon Corporation JPY 341.99B 13.69B Jun/2026
Pacific Biosciences Of California USD 68.81M 3.45M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sony JPY 4.92T 115.76B Jun/2026
Standard Biotools USD 42.2M 66.1M Mar/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Waters USD 2.27B 1.03B Mar/2026